skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Pharmacogenomics and Personalized Medicine

(205,217) Views

Editor in Chief Dr Martin H Bluth

1178-7066

Original Research
ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics
Barratt DT, Coller JK, Hallinan R, Byrne A, White JM, Foster DJR, Somogyi AA
Pharmacogenomics and Personalized Medicine 2012, 5:53-62
18 April 2012

Review
The role of genetics in pre-eclampsia and potential pharmacogenomic interventions
Williams PJ, Morgan L
Pharmacogenomics and Personalized Medicine 2012, 5:37-51
20 January 2012 NB
Noteworthy comment: In this manuscript Williams and Morgan discuss and review the genetic and pharmacogenetics aspects of pre-eclampsia and address the pharmacogenomics of anti-platelet agents, alpha and beta blockers, calcium channel blockers and magnesium sulphate in relation to the treatment and prevention of pre-eclampsia.


Review
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy
Kenna GA, Roder-Hanna N, Leggio L, Zywiak WH, Clifford J, Edwards S, Kenna JA, Shoaff J, Swift RM
Pharmacogenomics and Personalized Medicine 2012, 5:19-35
13 January 2012 NB
Noteworthy comment: In this article, Dr Kenna and colleagues review the 5-HT transporter (5-HTTLPR) polymorphism alleles (LA/LG/S) and their associations with many psychiatric disorders.


Review
Individualization of antiretroviral therapy
Pavlos R, Phillips EJ
Pharmacogenomics and Personalized Medicine 2012, 5:1-17
29 December 2011